These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23782624)

  • 1. Factors associated with treatment success in veterans with diabetes and hyperlipidemia: a retrospective study.
    Tressler MC; Greer N; Rector TS; Ishani A; Ercan-Fang N
    Diabetes Educ; 2013; 39(5):664-70. PubMed ID: 23782624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic determinants of response to statin medications.
    Cone C; Murata G; Myers O
    Am J Health Syst Pharm; 2011 Mar; 68(6):511-7. PubMed ID: 21378299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes.
    Vouri SM; Shaw RF; Waterbury NV; Egge JA; Alexander B
    J Manag Care Pharm; 2011 May; 17(4):304-12. PubMed ID: 21534641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study.
    Schleyer T; Hui S; Wang J; Zhang Z; Knapp K; Baker J; Chase M; Boggs R; Simpson RJ
    J Manag Care Spec Pharm; 2019 May; 25(5):544-554. PubMed ID: 31039062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus.
    Timbie JW; Hayward RA; Vijan S
    Arch Intern Med; 2010 Jun; 170(12):1037-44. PubMed ID: 20585069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.
    Stark Casagrande S; Fradkin JE; Saydah SH; Rust KF; Cowie CC
    Diabetes Care; 2013 Aug; 36(8):2271-9. PubMed ID: 23418368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
    Brath H; Wascher TC; Kästenbauer T; Toplak H
    MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.
    Itoh H; Komuro I; Takeuchi M; Akasaka T; Daida H; Egashira Y; Fujita H; Higaki J; Hirata KI; Ishibashi S; Isshiki T; Ito S; Kashiwagi A; Kato S; Kitagawa K; Kitakaze M; Kitazono T; Kurabayashi M; Miyauchi K; Murakami T; Murohara T; Node K; Ogawa S; Saito Y; Seino Y; Shigeeda T; Shindo S; Sugawara M; Sugiyama S; Terauchi Y; Tsutsui H; Ueshima K; Utsunomiya K; Yamagishi M; Yamazaki T; Yo S; Yokote K; Yoshida K; Yoshimura M; Yoshimura N; Nakao K; Nagai R;
    Diabetes Obes Metab; 2019 Apr; 21(4):791-800. PubMed ID: 30393955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
    Breuker C; Clement F; Mura T; Macioce V; Castet-Nicolas A; Audurier Y; Boegner C; Morcrette E; Jalabert A; Villiet M; Avignon A; Sultan A
    Int J Cardiol; 2018 Oct; 268():195-199. PubMed ID: 30041785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.
    Modjtahedi BS; Wu J; Luong TQ; Gandhi NK; Fong DS; Chen W
    Ophthalmology; 2021 Aug; 128(8):1169-1179. PubMed ID: 33359888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal trends and predictors of statin use among patients with diabetes.
    Brennan MB; Huang ES; Lobo JM; Kang H; Guihan M; Basu A; Sohn MW
    J Diabetes Complications; 2018 Jan; 32(1):27-33. PubMed ID: 29107453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems.
    Schroeder EB; Hanratty R; Beaty BL; Bayliss EA; Havranek EP; Steiner JF
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):645-53. PubMed ID: 22851534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can group medical clinics improve lipid management in diabetes?
    Crowley MJ; Melnyk SD; Ostroff JL; Fredrickson SK; Jeffreys AS; Coffman CJ; Edelman D
    Am J Med; 2014 Feb; 127(2):145-51. PubMed ID: 24462012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does diabetes care differ by type of chronic comorbidity?: An evaluation of the Piette and Kerr framework.
    Pentakota SR; Rajan M; Fincke BG; Tseng CL; Miller DR; Christiansen CL; Kerr EA; Pogach LM
    Diabetes Care; 2012 Jun; 35(6):1285-92. PubMed ID: 22432109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
    Wang X; He Y; Wang T; Li C; Ma Z; Zhang H; Ma H; Zhao H
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Strict Versus Lenient Cholesterol Lowering with Cardiac Outcomes, Diabetes Progression and Complications, and Mortality in Patients with Diabetes Treated with Statins: Is Less More?
    Odeleye V; Masarweh O; Restrepo J; Alvarez CA; Mansi IA
    Drug Saf; 2023 Nov; 46(11):1105-1116. PubMed ID: 37782373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.